A Study of JNJ 10229570-AAA to Evaluate Safety and Tolerability in Japanese Participants With Acne Vulgaris

Inclusion Criteria: * Have Acne vulgaris, presenting at least inflammatory lesion on the face * Body mass index between 18.0 and 30.0 kg/m2 (inclusive), and body weight not less than 50 kg (man) or 45 kg (woman) * Blood pressure between 90 and 140 mmHg systolic (inclusive), and no higher than 90 mmHg diastolic * Electrocardiogram (ECG) consistent with normal cardiac conduction and function * Non-smoker * Adequate contraception method for both men and women. If a woman, must have a negative pregnancy test * Signed an informed consent document Exclusion Criteria: * History of or current clinically significant medical illness that the investigator considers should exclude the participant or that could interfere with the interpretation of the study results * Clinically significant abnormal values for hematology, biochemistry or urinalysis * Clinically significant abnormal physical examination, vital signs or ECG - Use of any prescription or nonprescription medication within 14 days before the study treatment * History of drug or alcohol abuse within the past 5 years * Drug allergy or drug hypersensitivity * Blood donation, depending on the volume of blood collection * Positive test for human immunodeficiency virus (HIV), hepatitis B or C, or syphilis * Dermatological disease at application site * Photosensitivity * Exposure to excessive or chronic ultraviolet (UV) radiation (i.e., sunbathing, tanning salon use, phototherapy) within 4 weeks prior to study treatment or planned during the study period